Task forces call for more studies on transfusion and CFS

03/7/2011 | Wall Street Journal, The

More studies need to be performed to determine whether XMRV poses a risk to the U.S. blood supply and whether there is any evidence that blood transfusion is linked to the development of chronic fatigue syndrome. Separate reports, published in the journal Transfusion by the HHS Blood XMRV Scientific Research Working Group and the AABB-facilitated XMRV task force, found no conclusive evidence of the latter. The studies come after a 2009 study in Science found that 67% of 101 CFS patients and 4% of healthy subjects involved had the XMRV retrovirus.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA